IGM Biosciences Inc. (NASDAQ: IGMS) reported Q3 EPS of ($1.01), $0.21 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $520 thousand versus the consensus estimate of $230.56 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.